Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 40.32
-0.38 (-0.93%)
At close: Mar 30, 2026
Hinova Pharmaceuticals Revenue
In the year 2025, Hinova Pharmaceuticals had annual revenue of 20.67M CNY with 5,535.71% growth. Hinova Pharmaceuticals had revenue of -2.68M in the quarter ending December 31, 2025.
Revenue
20.67M
Revenue Growth
+5,535.71%
P/S Ratio
193.11
Revenue / Employee
118.81K
Employees
174
Market Cap
3.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.67M | 20.31M | 5,535.71% |
| Dec 31, 2024 | 366.84K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.65M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.69B |
| Hefei Lifeon Pharmaceutical | 1.47B |
| Qingdao Vland Biotech INC. | 1.39B |
| Pulike Biological Engineering | 1.10B |
| Boji Medical Technology | 770.19M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Guanhao Biotech | 387.75M |
| Jiangsu Bioperfectus Technologies | 340.38M |